Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
24,073
+17,581
+271% +$786K 0.02% 1042
2026
Q1
$313K Sell
6,492
-67,064
-91% -$3.13M 0.01% 1366
2025
Q4
$3.56M Buy
73,556
+55,631
+310% +$2.76M 0.08% 350
2025
Q3
$846K Sell
17,925
-64,283
-78% -$3.1M 0.02% 1055
2025
Q2
$3.97M Buy
+82,208
New +$4.2M 0.1% 295

Other funds holding SNY

Y-Intercept (HK)'s SNY Position: Q2 2026 in Review

Y-Intercept (HK) increased its Sanofi (SNY) stake by 271% in Q2 2026, buying an estimated $786K and bringing the position to 24,073 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #1042.

Y-Intercept (HK) first reported a position in SNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.97M in Q2 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Y-Intercept (HK) held 24,073 shares of Sanofi worth $1.03M as of Q2 2026.
  • Y-Intercept (HK) bought 17,581 Sanofi shares in Q2 2026, an estimated $786K.
  • Sanofi made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1042 holding.
  • Y-Intercept (HK) first reported a position in Sanofi in Q2 2025 and has held it in 5 quarters since.
  • Y-Intercept (HK)'s Sanofi position peaked at $3.97M in Q2 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.